Community report · What Reddit says
SLU-PP-332 reddit: Exercise in a Pill?

SLU-PP-332 Reddit discussion treats “exercise in a pill” as both a scientific idea and a product claim. The science is worth watching: an ERR agonist changed muscle metabolism and improved treadmill endurance in mice. The product claim runs far ahead. No published human trial has established benefits, safety, absorption, or a dose.
Why does Reddit call SLU-PP-332 “exercise in a pill”?
SLU-PP-332 earned the nickname because it activated part of an aerobic-exercise gene program and improved endurance in mice without training. The compound activates estrogen-related receptors alpha, beta, and gamma, or ERRs. Despite the name, ERRs are not estrogen receptors; they help control mitochondrial activity, fuel use, and oxidative muscle—the machinery that supports sustained aerobic work.
The 2023 primary study found that SLU-PP-332 increased cellular respiration in muscle cells, shifted mouse muscle toward more oxidative type IIa fibers, and increased running endurance (PMID 36988910). That is a coherent preclinical result, not marketing confetti. It is also a mouse result. The full SLU-PP-332 evidence profile grades the headline evidence animal-only, none in humans.
What SLU-PP-332 results do Reddit users discuss?
SLU-PP-332 results on peptide Reddit cluster around more workout energy, easier cardio, increased sweating, fat loss, and sometimes no noticeable effect. Discussion also spills into oral-versus-injectable arguments, solvent problems, mitochondrial stacks, and whether any labeled product contains the compound claimed. These are recurring anecdotes, not controlled observations.
The metabolic paper gives those conversations a real scientific starting point. In obese mouse models, SLU-PP-332 increased energy expenditure and fatty-acid oxidation, reduced fat accumulation, and improved insulin sensitivity (PMID 37739806). The same paper found no improvement in glucose tolerance in healthy chow-fed mice. That boundary matters: the result depended on the model, and neither group was human.
The live SERP mostly repeats “fat burning,” “exercise mimetic,” and protocol language. The missing piece is attribution. A person who feels warmer after an unverified product has not replicated a mouse metabolism experiment. The compound, dose, route, diet, training, other drugs, and expectation are all uncontrolled at once.
Is SLU-PP-332 a peptide or an ERR agonist?
SLU-PP-332 is a synthetic small-molecule ERR agonist, not a peptide. PubChem lists a molecular weight of 290.3 g/mol and formula C18H14N2O2 (PubChem CID 5338394). A peptide is a chain of amino acids; SLU-PP-332 has no amino-acid sequence. Reddit’s category label describes the neighborhood, not the chemistry.
That distinction also sharpens comparisons. The longevity and metabolic research hub includes compounds with very different structures and mechanisms. Similar goals do not make two agents interchangeable, and separate pathways do not prove that a stack is effective or safe.
What is the SLU-PP-332 dosage discussed on Reddit?
No human SLU-PP-332 dosage has been established, and Reddit offers conflicting schedules rather than clinical evidence. The mouse research used intraperitoneal injection: 50 mg/kg in the endurance experiments and 50 mg/kg twice daily in the metabolic study. Those are study methods in mice, not a human protocol and not a number to copy by arithmetic.
The slu pp 332 reddit debate ranges across micrograms, milligrams, oral products, and injections. That spread is the finding: there is no validated human exposure target beneath the confident numbers. The published mouse work does not establish human oral bioavailability, injection safety, or a human half-life. A labeled capsule or vial cannot fill those gaps by existing.
Is SLU-PP-332 FDA-approved or banned in sport in 2026?
SLU-PP-332 is not FDA-approved for any use in the United States as of July 16, 2026. No product appears under that name in Drugs@FDA, the FDA database for approved human drugs. Online sale does not make a chemical an approved drug, dietary supplement ingredient, or recognized compounded medicine.
For tested athletes, the 2026 WADA list is broader than a name-by-name catalog. Class S0 prohibits pharmacological substances without current approval from a governmental health authority for human therapeutic use, at all times. SLU-PP-332 fits that non-approved category even though the list does not name it individually. The phrase research use only has a narrower meaning than many storefronts imply.
Where is Reddit right—and where is it off?
Reddit is right that SLU-PP-332 is an unusual exercise-mimetic research lead with a clear receptor target and positive endurance and metabolism findings in mice. The community is also right to question oral absorption, product identity, and the huge disagreement around dosing. Those are not side issues; they expose how little human evidence exists.
Reddit is off when “mice ran farther” becomes “people can replace cardio,” or when a self-report becomes an SLU-PP-332 result without verifying the material. The slu-pp-332 reddit story often turns the exercise mimetic reddit label into one cheerful paragraph that compresses four evidence tiers: cells, mice, unverified products, and human anecdotes. They are not interchangeable. How peptide evidence is graded explains the separation.
SLU-PP-332 has earned further research, not a victory lap. The mouse work shows enough biological signal to justify better compounds and eventual human testing. Until human trials arrive, the clean answer remains animal-only: promising mechanism, positive mouse outcomes, and no established human benefit or protocol.
Where the discussion happens
- 1.r/Peptides — community discussion of SLU-PP-332
- 2.Billon et al., 2023 — SLU-PP-332 and exercise capacity (PMID 36988910)
- 3.Billon et al., 2024 — SLU-PP-332 in mouse metabolic syndrome (PMID 37739806)
- 4.SLU-PP-332 compound record — PubChem CID 5338394
- 5.Drugs@FDA — FDA-approved drug database
- 6.WADA 2026 Prohibited List